Showing results (91-100 of 247) with videos related to

Sort By:
Pageof 25
Internal Medicine Journal|February 2, 2018
Chronic myeloid leukaemia and tyrosine kinase inhibitor therapy: assessment and management of cardiovascular risk factorsDavid M Ross, Chris Arthur, Kate Burbury, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2011
Eradication of solid tumors using histone deacetylase inhibitors combined with immune-stimulating antibodiesAilsa J Christiansen, Alison West, Kellie-Marie Banks, et al.
Cancer Immunology Research|November 16, 2021
BET Inhibition Enhances TNF-Mediated Antitumor ImmunityLisa C Wellinger, Simon J Hogg, Dane M Newman, et al.
Blood|April 12, 2014
Id2 represses E2A-mediated activation of IL-10 expression in T cellsFrederick Masson, Margherita Ghisi, Joanna R Groom, et al.
Cell Reports|May 13, 2014
The drug vehicle and solvent N-methylpyrrolidone is an immunomodulator and antimyeloma compoundJake Shortt, Andy K Hsu, Benjamin P Martin, et al.
Histochemistry and Cell Biology|January 28, 2003
Expression of IFI 16 in epithelial cells and lymphoid tissuesWu Wei, Christopher J P Clarke, Gino R Somers, et al.
Molecular Cancer Therapeutics|November 4, 2025
Discovery and characterisation of VPRBP/DCAF1 kinase inhibitor analogues as microtubular destabilising agents with potent anti-myeloma activityOlivia Susanto, Emily Gruber, Cheng Mun Wun, et al.
Internal Medicine Journal|March 6, 2017
High rates of potentially infectious exposures between immunocompromised patients and their companion animals: an unmet need for educationGreta A Gurry, Veronique Campion, Chamath Premawardena, et al.
Bioinformatics (Oxford, England)|January 7, 2014
Socrates: identification of genomic rearrangements in tumour genomes by re-aligning soft clipped readsJan Schröder, Arthur Hsu, Samantha E Boyle, et al.
Pageof 25